DrugPatentWatch Database Preview

Valeant Bermuda Company Profile

« Back to Dashboard

What is the competitive landscape for VALEANT BERMUDA, and when can generic versions of VALEANT BERMUDA drugs launch?

VALEANT BERMUDA has eight approved drugs.

There are three US patents protecting VALEANT BERMUDA drugs.

There are ninety-two patent family members on VALEANT BERMUDA drugs in thirty-five countries and twenty-seven supplementary protection certificates in twelve countries.

Summary for Valeant Bermuda

International Patents:	92
US Patents:	3
Tradenames:	7
Ingredients:	7
NDAs:	8

Drugs and US Patents for Valeant Bermuda

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Bermuda	DERMATOP E EMOLLIENT	prednicarbate	CREAM;TOPICAL	020279-001	Oct 29, 1993	AB	RX	Yes	Yes
Valeant Bermuda	ZOVIRAX	acyclovir	OINTMENT;TOPICAL	018604-001	Mar 29, 1982	AB	RX	Yes	Yes
Valeant Bermuda	XERESE	acyclovir; hydrocortisone	CREAM;TOPICAL	022436-001	Jul 31, 2009		RX	Yes	Yes	7,223,387		Y
Valeant Bermuda	PENLAC	ciclopirox	SOLUTION;TOPICAL	021022-001	Dec 17, 1999	AT	RX	Yes	Yes
Valeant Bermuda	XERESE	acyclovir; hydrocortisone	CREAM;TOPICAL	022436-001	Jul 31, 2009		RX	Yes	Yes	6,514,980		Y
Valeant Bermuda	ELIDEL	pimecrolimus	CREAM;TOPICAL	021302-001	Dec 13, 2001		RX	Yes	Yes	6,423,722*PED				Y

Expired US Patents for Valeant Bermuda

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Valeant Bermuda	PENLAC	ciclopirox	SOLUTION;TOPICAL	021022-001	Dec 17, 1999	4,957,730
Valeant Bermuda	DERMATOP E EMOLLIENT	prednicarbate	CREAM;TOPICAL	020279-001	Oct 29, 1993	4,242,334
Valeant Bermuda	ELIDEL	pimecrolimus	CREAM;TOPICAL	021302-001	Dec 13, 2001	6,423,722*PED
Valeant Bermuda	XERESE	acyclovir; hydrocortisone	CREAM;TOPICAL	022436-001	Jul 31, 2009	6,514,980
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	019049-001	Sep 16, 1988	3,729,568
Valeant Bermuda	RETIN-A	tretinoin	CREAM;TOPICAL	017522-001	Approved Prior to Jan 1, 1982	3,729,568

International Patents for Valeant Bermuda Drugs

Country	Document Number	Estimated Expiration
Norway	316355
Germany	69923584
World Intellectual Property Organization (WIPO)	9901458
Czech Republic	9802340
Japan	5420583
World Intellectual Property Organization (WIPO)	0029027

Supplementary Protection Certificates for Valeant Bermuda Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
172	Luxembourg		PRODUCT NAME: SOLVAT ACETONIQUE DU CABAZITAXEL, OU DESIGNE SOLVAT ACETONIQUE DU DIMETHOXY DOCETAXEL OU SOLVAT ACETONIQUE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2A-BENZOYLOXY-5BETA,20-EPOXY-1-HYDROXY-7BETA,10A-DIMETHOXY-9-OXO-TAX-11-ENE-13A-YLE(ACETONATE DU CABAZITAXEL)
1304992/01	Switzerland		PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
/2001	Austria		PRODUCT NAME: ALITRETINOIN; REGISTRATION NO/DATE: EU/1/00/149/001 20001011
C/GB01/014	United Kingdom		PRODUCT NAME: ALITRETINOIN; REGISTERED: UK EU/1/00/149/001 20001018
2008000041	Germany		PRODUCT NAME: ADAPALEN IN KOMBINATION MIT BENZOYLPEROXID; NAT. REGISTRATION NO/DATE: 67913.00.00 20080229; FIRST REGISTRATION: DAENEMARK 40440 20071218
00617	Netherlands		PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Vale
• Valeant
• Valeant Bermuda
• Valeant Intl
• Valeant Luxembourg
• Valeant Pharm Intl